UNSPSC 51471601: Laurolinium acetate

This classification denotes an anti-infective agent with the molecular formula C22H35N2.C2H3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R01EZP92PU, chemically known as quinolinium, 4-amino-1-dodecyl-2-methyl-, acetate (9ci) but generally known as laurolinium acetate, which bears US NIH Compound Identifier 67354. European Medicines Agency schedules Laurolinium acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08416MIG.

UNSPSC 51471601 Laurolinium acetate is a Commodity code covering a specific antimicrobial and cleaning agent ingredient that state and local governments procure as part of broader janitorial, operational, and pharmaceutical supply contracts. Recent solicitations show the code appearing in consumable supplies procurement for public safety operations and in multi-state cooperative pharmaceutical and over-the-counter product frameworks, though the specific ingredient laurolinium acetate is not explicitly itemized in the available opportunity summaries—it surfaces as part of larger product categories where authorized bidders must supply compliant formulations and ingredients.

Issuing bodies under this code include county governments (Hillsborough County Board of County Commissioners in Florida) and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, administered by the Minnesota Department of Administration). The Hillsborough County Fire Rescue janitorial ITB posted July 7, 2026 with a due date of July 24, 2026 covers consumable supplies for 47 fire stations operating around the clock, with an estimated contract value of $765,679.84 and delivery requirements to Tampa, Florida; MMCAP's RFP S1070000015802 issued January 20, 2026 with a due date of March 26, 2026 establishes multi-state pharmaceutical and OTC product contracts effective July 1, 2026, serving participating state and local government facilities across Minnesota and Oregon. The Hillsborough solicitation requires new, unused products from authorized distributors with standard delivery within ten days, while the MMCAP framework mandates FDA compliance, cGMP certification, and Drug Supply Chain Security Act adherence, with pricing weighted at 75 percent of the evaluation. Geographic activity centers on Florida and the Upper Midwest, with the MMCAP cooperative extending across multiple states.